FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097727902> ?p ?o ?g. }

• W3097727902 endingPage "4073" @default.
• W3097727902 startingPage "4045" @default.
• W3097727902 abstract "// Niraj Lodhi 1 , 2 , * , Moe Tun 2 , * , Poonam Nagpal 2 , 3 , Arati A. Inamdar 2 , Nehad M. Ayoub 4 , Noor Siyam 2 , Lucia Oton-Gonzalez 5 , Angela Gerona 2 , Dainelle Morris 2 , Rana Sandhu 2 and Kwangsun Stephen Suh 2 , 6 1 Department of Immunotherapeutic and Biotechnology, Texas Tech Health Science Center, Abilene, TX, USA 2 Formerly: The Genomics and Biomarkers Program, John Theurer Cancer Center at Hackensack University Medical Center, David Jurist Research Building, Hackensack, NJ, USA 3 College of Natural, Applied, and Health Sciences, Kean University, Union, NJ, USA 4 Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan 5 Department of Medical Sciences, University of Ferrara, Ferrara, Italy 6 DiagnoCine, Hackensack, NJ, USA * These authors contributed equally to this work Correspondence to: Kwangsun Stephen Suh, email: kstephensuh@gmail.com Keywords: DLBCL; diagnosis; R-CHOP; precision medicine; prognosis Received: June 03, 2020     Accepted: September 29, 2020     Published: November 03, 2020 Copyright: © 2020 Lodhi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Despite the great efforts for better treatment options for diffuse large B-cell lymphoma (DLBCL) (most common form of non-Hodgkin lymphoma, NHL) to treat and prevent relapse, it continues to be a challenge. Here, we present an overview of DLBCL and address the diagnostic assays and molecular techniques used in its diagnosis, role of biomarkers in detection, treatment of early and advanced stage DLBCL, and novel drug regimens. We discuss the significant biomarkers that have emerged as essential tools for stratifying patients according to risk factors and for providing insights into the use of more targeted and individualized therapeutics. We discuss techniques such as gene expression studies, including next-generation sequencing, which have enabled a more understanding of the complex pathogenesis of DLBCL and have helped determine molecular targets for novel therapeutic agents. We examine current treatment approaches, outline the findings of completed clinical trials, and provide updates for ongoing clinical trials. We highlight clinical trials relevant to the significant fraction of DLBCL patients who present with complex cases marked by high relapse rates. Supported by an increased understanding of targetable pathways in DLBCL, clinical trials involving specialized combination therapies are bringing us within reach the promise of an effective cure to DLBCL using precision medicine. Optimization of therapy remains a crucial objective, with the end goal being a balance between high survival rates through targeted and personalized treatment while reducing adverse effects in DLBCL patients of all subsets." @default.
• W3097727902 created "2020-11-09" @default.
• W3097727902 creator A5010466825 @default.
• W3097727902 creator A5011049342 @default.
• W3097727902 creator A5013698826 @default.
• W3097727902 creator A5031646248 @default.
• W3097727902 creator A5033246720 @default.
• W3097727902 creator A5045806489 @default.
• W3097727902 creator A5047435547 @default.
• W3097727902 creator A5049372405 @default.
• W3097727902 creator A5059782250 @default.
• W3097727902 creator A5067966337 @default.
• W3097727902 creator A5085338531 @default.
• W3097727902 date "2020-11-03" @default.
• W3097727902 modified "2023-09-26" @default.
• W3097727902 title "Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine" @default.
• W3097727902 cites W1020989877 @default.
• W3097727902 cites W1049067418 @default.
• W3097727902 cites W1094999820 @default.
• W3097727902 cites W111238660 @default.
• W3097727902 cites W1223416685 @default.
• W3097727902 cites W1514315761 @default.
• W3097727902 cites W1531816163 @default.
• W3097727902 cites W1536179996 @default.
• W3097727902 cites W1536736511 @default.
• W3097727902 cites W1743709057 @default.
• W3097727902 cites W1854285593 @default.
• W3097727902 cites W1931280990 @default.
• W3097727902 cites W1937502920 @default.
• W3097727902 cites W1964840824 @default.
• W3097727902 cites W1972153960 @default.
• W3097727902 cites W1973001092 @default.
• W3097727902 cites W1975213528 @default.
• W3097727902 cites W1976402300 @default.
• W3097727902 cites W1976564639 @default.
• W3097727902 cites W1976731794 @default.
• W3097727902 cites W1977267072 @default.
• W3097727902 cites W1977635491 @default.
• W3097727902 cites W1977824829 @default.
• W3097727902 cites W1979199037 @default.
• W3097727902 cites W1979781733 @default.
• W3097727902 cites W1979816280 @default.
• W3097727902 cites W1987217502 @default.
• W3097727902 cites W1987642183 @default.
• W3097727902 cites W1988703453 @default.
• W3097727902 cites W1989707023 @default.
• W3097727902 cites W1990045094 @default.
• W3097727902 cites W1996699413 @default.
• W3097727902 cites W1997393575 @default.
• W3097727902 cites W1997765594 @default.
• W3097727902 cites W2006885289 @default.
• W3097727902 cites W2007548746 @default.
• W3097727902 cites W2013670229 @default.
• W3097727902 cites W2014485235 @default.
• W3097727902 cites W2016969330 @default.
• W3097727902 cites W2018796139 @default.
• W3097727902 cites W2020045401 @default.
• W3097727902 cites W2020789296 @default.
• W3097727902 cites W2029823192 @default.
• W3097727902 cites W2030736011 @default.
• W3097727902 cites W2031855605 @default.
• W3097727902 cites W2032310238 @default.
• W3097727902 cites W2035135710 @default.
• W3097727902 cites W2037382204 @default.
• W3097727902 cites W2037796411 @default.
• W3097727902 cites W2038989901 @default.
• W3097727902 cites W2042652801 @default.
• W3097727902 cites W2044306036 @default.
• W3097727902 cites W2044352858 @default.
• W3097727902 cites W2045399297 @default.
• W3097727902 cites W2046859845 @default.
• W3097727902 cites W2054358414 @default.
• W3097727902 cites W2054861724 @default.
• W3097727902 cites W2056641238 @default.
• W3097727902 cites W2059470125 @default.
• W3097727902 cites W2059495814 @default.
• W3097727902 cites W2060610804 @default.
• W3097727902 cites W2061621597 @default.
• W3097727902 cites W2067578715 @default.
• W3097727902 cites W2068343048 @default.
• W3097727902 cites W2069778927 @default.
• W3097727902 cites W2070601685 @default.
• W3097727902 cites W2071959000 @default.
• W3097727902 cites W2072646319 @default.
• W3097727902 cites W2073052834 @default.
• W3097727902 cites W2074203591 @default.
• W3097727902 cites W2076726977 @default.
• W3097727902 cites W2079069420 @default.
• W3097727902 cites W2085927974 @default.
• W3097727902 cites W2089156445 @default.
• W3097727902 cites W2089717366 @default.
• W3097727902 cites W2089783130 @default.
• W3097727902 cites W2091213817 @default.
• W3097727902 cites W2096406358 @default.
• W3097727902 cites W2097304927 @default.
• W3097727902 cites W2097561270 @default.
• W3097727902 cites W2100197564 @default.
• W3097727902 cites W2102472975 @default.

• next